Evidence map›Paper›PMID 42356427›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Lactoferrin Displays Stimulating and Protective Effects on Newly Isolated Phage vB_Sau-E: A New Perspective for Treatment of Staphylococcal Skin Infections.

Urszula Leszczyńska, Małgorzata Stasiłojć, Milena Grzenkowicz, Magdalena Narajczyk, Agnieszka Necel, Lidia Piechowicz, Katarzyna Kosznik-Kwaśnicka, Anna Żywicka

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Urszula LeszczyńskaStudent Scientific Circle of Medical Microbiology, Department of Medical Microbiology, Faculty of Medicine, Medical University of Gdańsk, 80-204 Gdańsk, Poland.
Małgorzata StasiłojćDepartment of Cell Biology and Immunology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, 80-211 Gdańsk, Poland.ORCID 0000-0003-4221-5803
Milena GrzenkowiczDepartment of Medical Microbiology, Faculty of Medicine, Medical University of Gdańsk, 80-204 Gdańsk, Poland.ORCID 0009-0004-0141-1749
Magdalena NarajczykBioimaging Laboratory, Faculty of Biology, University of Gdańsk, 80-308 Gdańsk, Poland.ORCID 0000-0001-9806-8844
Agnieszka NecelDepartment of Medical Microbiology, Faculty of Medicine, Medical University of Gdańsk, 80-204 Gdańsk, Poland.ORCID 0000-0002-9051-4077
Lidia PiechowiczDepartment of Medical Microbiology, Faculty of Medicine, Medical University of Gdańsk, 80-204 Gdańsk, Poland.ORCID 0000-0001-9222-7330
Katarzyna Kosznik-KwaśnickaDepartment of Medical Microbiology, Faculty of Medicine, Medical University of Gdańsk, 80-204 Gdańsk, Poland.ORCID 0000-0002-5023-1531
Anna ŻywickaDepartment of Microbiology and Biotechnology, Faculty of Biotechnology and Animal Husbandry, West Pomeranian University of Technology in Szczecin, 71-270 Szczecin, Poland.ORCID 0000-0002-0630-7252

Funding

National Science Centre 2023/51/D/NZ3/0185
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bacteriophagesMRSAphage therapyskin infectionsStaphylococcus aureus

Identifiers

PMID42356427
PMCPMC13306224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.